Equities were mostly higher in November despite concerns over the US budget deficit. Positive economic indicators included better-than-expected jobless claims and GDP growth, as well as rising housing prices and consumer confidence. On November 29, US third-quarter GDP growth was revised upward from 2.0% to 2.7%, primarily due to inventory investments. For the month, the […]
Santa Clara, CA and Penzberg, Germany 11/7/12—Agilent Technologies will be the exclusive provider of continued services to Roche NimbleGen customers as Roche phases out its NimbleGen microarray production and services. Roche and Agilent announced that customers can transition to Agilent arrays with minimal disruption for all applications because of the technologies’ similarities. “Our field service […]
San Diego, CA 11/12/12—Illumina announced that VWR International will distribute its qPCR portfolio, including the Eco Real-Time PCR System and the NuPCR reagents, in the US. “We are very excited to join forces with VWR to accelerate adoption of our qPCR portfolio, particularly into the pharmaceutical and industrial markets where VWR has a strong presence,” […]
Paris, France 10/22/12; Paris France 10/22/12—Publicly held French energy firm AREVA has entered into exclusive negotiations with private equity company Astorg Partners to sell its Canberra radiation measurement business. AREVA is divesting assets in order to reduce debt and finance new investments.
Egham, UK 11/26/12—Spectris has agreed to acquire Analytical Spectral Devices (ASD) for $14 million, excluding debt and cash. In addition, a contingent consideration of up to $19 million will be payable based on sales through December 2015. ASD is a provider of NIR instrumentation solutions and application expertise for materials measurement and research. “ASD’s successful […]
Mountain View, CA and Shenzhen, China 9/17/12; Washington, DC 11/13/12; Washington DC, 11/21/12; Washington DC 11/25/12; Washington, DC 11/27/12—Publicly held Complete Genomics, a provider of DNA sequencing services, has rejected an offer by Illumina to acquire the company. On November 20, Illumina submitted a $3.30 per share unsolicited offer for the firm. In September, Complete […]
Major publicly held instrument and laboratory product businesses continued to weather a slow growth environment in the calendar-year third quarter. Revenues for the eight businesses whose quarterly results are detailed on pages 9–11 grew 2.0%, including approximately 4.2% organic growth (see table, page 9). This compares with reported sales growth of 3.1% last quarter, with […]
Even excluding American Recovery and Reinvestment Act (ARRA) funding, US university spending on R&D continued to grow in fiscal year 2011 (FY11) (ending June 30, 2011). Without ARRA funding, university spending on R&D would have grown 4.0% to $60.9 billion, according to the NSF’s Higher Education Research and Development (HERD) Survey. Including ARRA funds, university […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
